Science Weekly What’s behind the injectable peptide craze?
18 snips
Mar 17, 2026 Dr Anna Barnard, Imperial College researcher on peptide therapeutics, and Adrienne Matei, lifestyle journalist at The Guardian US, explore the rise of grey‑market injectable peptides. They trace who uses them and why. They outline where these products come from and what peptides do. They discuss potential therapeutic directions and the safety, cultural and regulatory debates driving the craze.
AI Snips
Chapters
Transcript
Episode notes
Peptides Have Moved From Fringe Labs To Mainstream Wellness
- Grey‑market injectable peptides have moved from niche biohacking into mainstream wellness culture driven by influencers and optimisation communities.
- Examples include BPC‑157, GHK‑Cu and TB‑500 hyped for healing, skin and hair, often promoted on social media as miracle fixes.
Communities Driving Peptide Use Include Biohackers And Looks‑Maxers
- Adrienne Matei traces current peptide popularity to bodybuilding, Silicon Valley biohackers, looks‑maxers and middle‑aged forums sharing self‑experiments.
- She notes GLP‑1s normalized at‑home injections, and communities call peptides 'peppers' with stacks like 'Wolverine' or 'Glow'.
Grey Market Supply Chains Are Opaque And Unregulated
- Most grey‑market peptides are sold labelled 'for research purposes only' but widely marketed and purchased for self‑administration.
- Buyers source them from Chinese manufacturers or compounding pharmacies with opaque supply chains.